Clinical Trial Update: A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the effect of Aumolertinib on the pharmacokinetics of midazolam in patients with non-small cell lung cancer. It investigates potenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aumolertinib (Aumolertinib)
• Midazolam (Midazolam)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING